Czech National Bank’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.54M Buy
23,340
+763
+3% +$201K 0.04% 360
2026
Q1
$6.02M Buy
22,577
+717
+3% +$194K 0.04% 351
2025
Q4
$5.48M Buy
21,860
+754
+4% +$200K 0.04% 365
2025
Q3
$6.06M Buy
21,106
+647
+3% +$173K 0.04% 334
2025
Q2
$5.37M Buy
20,459
+1,304
+7% +$318K 0.04% 344
2025
Q1
$4.46M Buy
19,155
+1,020
+6% +$248K 0.04% 364
2024
Q4
$4.16M Buy
18,135
+1,031
+6% +$237K 0.04% 371
2024
Q3
$3.82M Buy
17,104
+1,040
+6% +$229K 0.04% 376
2024
Q2
$3.27M Buy
16,064
+1,126
+8% +$229K 0.04% 376
2024
Q1
$3.26M Buy
14,938
+68
+0.5% +$15K 0.04% 364
2023
Q4
$3.38M Sell
14,870
-616
-4% -$129K 0.05% 341
2023
Q3
$3.11M Buy
15,486
+3,278
+27% +$691K 0.05% 331
2023
Q2
$2.53M Buy
12,208
+64
+0.5% +$12.4K 0.06% 313
2023
Q1
$2.39M Buy
12,144
+72
+0.6% +$14.8K 0.06% 316
2022
Q4
$2.44M Sell
12,072
-157
-1% -$30.7K 0.06% 306
2022
Q3
$2.15M Buy
+12,229
New +$2.5M 0.06% 317

Other funds holding LH

Czech National Bank's LH Position: Q2 2026 in Review

Czech National Bank increased its Labcorp (LH) stake by 3.4% in Q2 2026, buying an estimated $201K and bringing the position to 23,340 shares worth $6.54M. The position accounts for 0.04% of the portfolio, ranked #360.

Czech National Bank first reported a position in LH in Q3 2022 and has held it in 16 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Czech National Bank held 23,340 shares of Labcorp worth $6.54M as of Q2 2026.
  • Czech National Bank bought 763 Labcorp shares in Q2 2026, an estimated $201K.
  • Labcorp made up 0.04% of Czech National Bank's portfolio in Q2 2026, its #360 holding.
  • Czech National Bank first reported a position in Labcorp in Q3 2022 and has held it in 16 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.